Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
ACTIVE NOT RECRUITING
NCT02531087

Urinary Biomarkers of OI Pathobiology

Sponsor: Baylor College of Medicine

View on ClinicalTrials.gov

Summary

Osteogenesis imperfecta (OI) is a rare inherited disorder that causes bones to break easily. Individuals with osteogenesis imperfecta break bones often and may have other problems, including hearing loss, dental problems, pain and difficulty getting around. Before the genetic cause of OI was known, OI was classified into four types. Each type was based upon the symptoms and severity of OI. In most people with OI, the cause is a change in one of the genes that makes a protein called type 1 collagen. Some doctors now classify OI both on how severe it is as well as which gene is causing OI. When people classify OI this way, there are more than 10 types of OI. The current laboratory testing to determine OI subtype involves the collection of blood and/or skin cells.

Official title: Cross-Linked Collagen Peptides as a Urinary Biomarker of OI Pathobiology

Key Details

Gender

All

Age Range

Any - Any

Study Type

OBSERVATIONAL

Enrollment

25

Start Date

2015-08-17

Completion Date

2026-08-31

Last Updated

2025-12-01

Healthy Volunteers

Yes

Locations (7)

University of California Los Angeles

Los Angeles, California, United States

University of Nebraska Medical Center

Omaha, Nebraska, United States

Hospital for Special Surgery

New York, New York, United States

Oregon Health Science University

Portland, Oregon, United States

Baylor College of Medicine

Houston, Texas, United States

Shriners Hospital for Children

Milwauke, Wisconsin, United States

Shriners Hospital for Children

Montreal, Quebec, Canada